0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vaccine Technologies Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-30Z5715
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global and United States Vaccine Technologies Market Report Forecast 2022 2028
BUY CHAPTERS

Global Vaccine Technologies Market Insights, Forecast to 2030

Code: QYRE-Auto-30Z5715
Report
December 2024
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Vaccine Technologies Market Size

The global Vaccine Technologies market is projected to grow from US$ 48410 million in 2024 to US$ 66780 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period.

Vaccine Technologies Market

Vaccine Technologies Market

Vaccine technologies have been in development since the initial use of killed viral and killed bacterial vaccines.
Market Analysis and Insights: Global Vaccine Technologies Market
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Vaccine Technologies market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Vaccine Technologies, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Vaccine Technologies, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Vaccine Technologies revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Vaccine Technologies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Vaccine Technologies revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Vaccine Technologies Market Report

Report Metric Details
Report Name Vaccine Technologies Market
Accounted market size in 2024 US$ 48410 million
Forecasted market size in 2030 US$ 66780 million
CAGR 5.5
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
  • Infection
  • Allergy
  • Cancer
Segment by Application
  • Humans
  • Animals
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, Pfizer, Bayer, GE Healthcare, Glaxosmithkline, Johnson and Johnson, Thermo Fisher Scientific
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Vaccine Technologies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Vaccine Technologies companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vaccine Technologies revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Vaccine Technologies Market growing?

Ans: The Vaccine Technologies Market witnessing a CAGR of 5.5 during the forecast period 2025-2030.

What is the Vaccine Technologies Market size in 2030?

Ans: The Vaccine Technologies Market size in 2030 will be US$ 66780 million.

Who are the main players in the Vaccine Technologies Market report?

Ans: The main players in the Vaccine Technologies Market are Abbott, Pfizer, Bayer, GE Healthcare, Glaxosmithkline, Johnson and Johnson, Thermo Fisher Scientific

What are the Application segmentation covered in the Vaccine Technologies Market report?

Ans: The Applications covered in the Vaccine Technologies Market report are Humans, Animals

What are the Type segmentation covered in the Vaccine Technologies Market report?

Ans: The Types covered in the Vaccine Technologies Market report are Infection, Allergy, Cancer

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccine Technologies Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Infection
1.2.3 Allergy
1.2.4 Cancer
1.3 Market by Application
1.3.1 Global Vaccine Technologies Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Humans
1.3.3 Animals
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vaccine Technologies Market Perspective (2019-2030)
2.2 Global Vaccine Technologies Growth Trends by Region
2.2.1 Vaccine Technologies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Vaccine Technologies Historic Market Size by Region (2019-2024)
2.2.3 Vaccine Technologies Forecasted Market Size by Region (2025-2030)
2.3 Vaccine Technologies Market Dynamics
2.3.1 Vaccine Technologies Industry Trends
2.3.2 Vaccine Technologies Market Drivers
2.3.3 Vaccine Technologies Market Challenges
2.3.4 Vaccine Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Vaccine Technologies by Players
3.1.1 Global Vaccine Technologies Revenue by Players (2019-2024)
3.1.2 Global Vaccine Technologies Revenue Market Share by Players (2019-2024)
3.2 Global Vaccine Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Vaccine Technologies, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Vaccine Technologies Market Concentration Ratio
3.4.1 Global Vaccine Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccine Technologies Revenue in 2023
3.5 Global Key Players of Vaccine Technologies Head office and Area Served
3.6 Global Key Players of Vaccine Technologies, Product and Application
3.7 Global Key Players of Vaccine Technologies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaccine Technologies Breakdown Data by Type
4.1 Global Vaccine Technologies Historic Market Size by Type (2019-2024)
4.2 Global Vaccine Technologies Forecasted Market Size by Type (2025-2030)
5 Vaccine Technologies Breakdown Data by Application
5.1 Global Vaccine Technologies Historic Market Size by Application (2019-2024)
5.2 Global Vaccine Technologies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Vaccine Technologies Market Size (2019-2030)
6.2 North America Vaccine Technologies Market Size by Type
6.2.1 North America Vaccine Technologies Market Size by Type (2019-2024)
6.2.2 North America Vaccine Technologies Market Size by Type (2025-2030)
6.2.3 North America Vaccine Technologies Market Share by Type (2019-2030)
6.3 North America Vaccine Technologies Market Size by Application
6.3.1 North America Vaccine Technologies Market Size by Application (2019-2024)
6.3.2 North America Vaccine Technologies Market Size by Application (2025-2030)
6.3.3 North America Vaccine Technologies Market Share by Application (2019-2030)
6.4 North America Vaccine Technologies Market Size by Country
6.4.1 North America Vaccine Technologies Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Vaccine Technologies Market Size by Country (2019-2024)
6.4.3 North America Vaccine Technologies Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Vaccine Technologies Market Size (2019-2030)
7.2 Europe Vaccine Technologies Market Size by Type
7.2.1 Europe Vaccine Technologies Market Size by Type (2019-2024)
7.2.2 Europe Vaccine Technologies Market Size by Type (2025-2030)
7.2.3 Europe Vaccine Technologies Market Share by Type (2019-2030)
7.3 Europe Vaccine Technologies Market Size by Application
7.3.1 Europe Vaccine Technologies Market Size by Application (2019-2024)
7.3.2 Europe Vaccine Technologies Market Size by Application (2025-2030)
7.3.3 Europe Vaccine Technologies Market Share by Application (2019-2030)
7.4 Europe Vaccine Technologies Market Size by Country
7.4.1 Europe Vaccine Technologies Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Vaccine Technologies Market Size by Country (2019-2024)
7.4.3 Europe Vaccine Technologies Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Vaccine Technologies Market Size (2019-2030)
8.2 China Vaccine Technologies Market Size by Type
8.2.1 China Vaccine Technologies Market Size by Type (2019-2024)
8.2.2 China Vaccine Technologies Market Size by Type (2025-2030)
8.2.3 China Vaccine Technologies Market Share by Type (2019-2030)
8.3 China Vaccine Technologies Market Size by Application
8.3.1 China Vaccine Technologies Market Size by Application (2019-2024)
8.3.2 China Vaccine Technologies Market Size by Application (2025-2030)
8.3.3 China Vaccine Technologies Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Vaccine Technologies Market Size (2019-2030)
9.2 Asia Vaccine Technologies Market Size by Type
9.2.1 Asia Vaccine Technologies Market Size by Type (2019-2024)
9.2.2 Asia Vaccine Technologies Market Size by Type (2025-2030)
9.2.3 Asia Vaccine Technologies Market Share by Type (2019-2030)
9.3 Asia Vaccine Technologies Market Size by Application
9.3.1 Asia Vaccine Technologies Market Size by Application (2019-2024)
9.3.2 Asia Vaccine Technologies Market Size by Application (2025-2030)
9.3.3 Asia Vaccine Technologies Market Share by Application (2019-2030)
9.4 Asia Vaccine Technologies Market Size by Region
9.4.1 Asia Vaccine Technologies Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Vaccine Technologies Market Size by Region (2019-2024)
9.4.3 Asia Vaccine Technologies Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Vaccine Technologies Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Vaccine Technologies Market Size by Type
10.2.1 Middle East, Africa, and Latin America Vaccine Technologies Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Vaccine Technologies Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Vaccine Technologies Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Vaccine Technologies Market Size by Application
10.3.1 Middle East, Africa, and Latin America Vaccine Technologies Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Vaccine Technologies Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Vaccine Technologies Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Vaccine Technologies Market Size by Country
10.4.1 Middle East, Africa, and Latin America Vaccine Technologies Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Vaccine Technologies Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Vaccine Technologies Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Vaccine Technologies Introduction
11.1.4 Abbott Revenue in Vaccine Technologies Business (2019-2024)
11.1.5 Abbott Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Vaccine Technologies Introduction
11.2.4 Pfizer Revenue in Vaccine Technologies Business (2019-2024)
11.2.5 Pfizer Recent Developments
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Vaccine Technologies Introduction
11.3.4 Bayer Revenue in Vaccine Technologies Business (2019-2024)
11.3.5 Bayer Recent Developments
11.4 GE Healthcare
11.4.1 GE Healthcare Company Details
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare Vaccine Technologies Introduction
11.4.4 GE Healthcare Revenue in Vaccine Technologies Business (2019-2024)
11.4.5 GE Healthcare Recent Developments
11.5 Glaxosmithkline
11.5.1 Glaxosmithkline Company Details
11.5.2 Glaxosmithkline Business Overview
11.5.3 Glaxosmithkline Vaccine Technologies Introduction
11.5.4 Glaxosmithkline Revenue in Vaccine Technologies Business (2019-2024)
11.5.5 Glaxosmithkline Recent Developments
11.6 Johnson and Johnson
11.6.1 Johnson and Johnson Company Details
11.6.2 Johnson and Johnson Business Overview
11.6.3 Johnson and Johnson Vaccine Technologies Introduction
11.6.4 Johnson and Johnson Revenue in Vaccine Technologies Business (2019-2024)
11.6.5 Johnson and Johnson Recent Developments
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Details
11.7.2 Thermo Fisher Scientific Business Overview
11.7.3 Thermo Fisher Scientific Vaccine Technologies Introduction
11.7.4 Thermo Fisher Scientific Revenue in Vaccine Technologies Business (2019-2024)
11.7.5 Thermo Fisher Scientific Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Vaccine Technologies Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Infection
    Table 3. Key Players of Allergy
    Table 4. Key Players of Cancer
    Table 5. Global Vaccine Technologies Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Vaccine Technologies Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Vaccine Technologies Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Vaccine Technologies Market Share by Region (2019-2024)
    Table 9. Global Vaccine Technologies Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Vaccine Technologies Market Share by Region (2025-2030)
    Table 11. Vaccine Technologies Market Trends
    Table 12. Vaccine Technologies Market Drivers
    Table 13. Vaccine Technologies Market Challenges
    Table 14. Vaccine Technologies Market Restraints
    Table 15. Global Vaccine Technologies Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Vaccine Technologies Revenue Share by Players (2019-2024)
    Table 17. Global Top Vaccine Technologies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Technologies as of 2023)
    Table 18. Global Vaccine Technologies Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Vaccine Technologies Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Vaccine Technologies, Headquarters and Area Served
    Table 21. Global Key Players of Vaccine Technologies, Product and Application
    Table 22. Global Key Players of Vaccine Technologies, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Vaccine Technologies Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Vaccine Technologies Revenue Market Share by Type (2019-2024)
    Table 26. Global Vaccine Technologies Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Vaccine Technologies Revenue Market Share by Type (2025-2030)
    Table 28. Global Vaccine Technologies Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Vaccine Technologies Revenue Share by Application (2019-2024)
    Table 30. Global Vaccine Technologies Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Vaccine Technologies Revenue Share by Application (2025-2030)
    Table 32. North America Vaccine Technologies Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Vaccine Technologies Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Vaccine Technologies Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Vaccine Technologies Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Vaccine Technologies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Vaccine Technologies Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Vaccine Technologies Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Vaccine Technologies Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Vaccine Technologies Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Vaccine Technologies Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Vaccine Technologies Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Vaccine Technologies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Vaccine Technologies Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Vaccine Technologies Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Vaccine Technologies Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Vaccine Technologies Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Vaccine Technologies Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Vaccine Technologies Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Vaccine Technologies Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Vaccine Technologies Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Vaccine Technologies Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Vaccine Technologies Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Vaccine Technologies Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Vaccine Technologies Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Vaccine Technologies Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Vaccine Technologies Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Vaccine Technologies Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Vaccine Technologies Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Vaccine Technologies Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Vaccine Technologies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Vaccine Technologies Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Vaccine Technologies Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Abbott Company Details
    Table 65. Abbott Business Overview
    Table 66. Abbott Vaccine Technologies Product
    Table 67. Abbott Revenue in Vaccine Technologies Business (2019-2024) & (US$ Million)
    Table 68. Abbott Recent Developments
    Table 69. Pfizer Company Details
    Table 70. Pfizer Business Overview
    Table 71. Pfizer Vaccine Technologies Product
    Table 72. Pfizer Revenue in Vaccine Technologies Business (2019-2024) & (US$ Million)
    Table 73. Pfizer Recent Developments
    Table 74. Bayer Company Details
    Table 75. Bayer Business Overview
    Table 76. Bayer Vaccine Technologies Product
    Table 77. Bayer Revenue in Vaccine Technologies Business (2019-2024) & (US$ Million)
    Table 78. Bayer Recent Developments
    Table 79. GE Healthcare Company Details
    Table 80. GE Healthcare Business Overview
    Table 81. GE Healthcare Vaccine Technologies Product
    Table 82. GE Healthcare Revenue in Vaccine Technologies Business (2019-2024) & (US$ Million)
    Table 83. GE Healthcare Recent Developments
    Table 84. Glaxosmithkline Company Details
    Table 85. Glaxosmithkline Business Overview
    Table 86. Glaxosmithkline Vaccine Technologies Product
    Table 87. Glaxosmithkline Revenue in Vaccine Technologies Business (2019-2024) & (US$ Million)
    Table 88. Glaxosmithkline Recent Developments
    Table 89. Johnson and Johnson Company Details
    Table 90. Johnson and Johnson Business Overview
    Table 91. Johnson and Johnson Vaccine Technologies Product
    Table 92. Johnson and Johnson Revenue in Vaccine Technologies Business (2019-2024) & (US$ Million)
    Table 93. Johnson and Johnson Recent Developments
    Table 94. Thermo Fisher Scientific Company Details
    Table 95. Thermo Fisher Scientific Business Overview
    Table 96. Thermo Fisher Scientific Vaccine Technologies Product
    Table 97. Thermo Fisher Scientific Revenue in Vaccine Technologies Business (2019-2024) & (US$ Million)
    Table 98. Thermo Fisher Scientific Recent Developments
    Table 99. Research Programs/Design for This Report
    Table 100. Key Data Information from Secondary Sources
    Table 101. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Vaccine Technologies Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Vaccine Technologies Market Share by Type: 2023 VS 2030
    Figure 3. Infection Features
    Figure 4. Allergy Features
    Figure 5. Cancer Features
    Figure 6. Global Vaccine Technologies Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Vaccine Technologies Market Share by Application: 2023 VS 2030
    Figure 8. Humans Case Studies
    Figure 9. Animals Case Studies
    Figure 10. Vaccine Technologies Report Years Considered
    Figure 11. Global Vaccine Technologies Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Vaccine Technologies Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Vaccine Technologies Market Share by Region: 2023 VS 2030
    Figure 14. Global Vaccine Technologies Market Share by Players in 2023
    Figure 15. Global Top Vaccine Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Technologies as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Vaccine Technologies Revenue in 2023
    Figure 17. North America Vaccine Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Vaccine Technologies Market Share by Type (2019-2030)
    Figure 19. North America Vaccine Technologies Market Share by Application (2019-2030)
    Figure 20. North America Vaccine Technologies Market Share by Country (2019-2030)
    Figure 21. United States Vaccine Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Vaccine Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Vaccine Technologies Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Vaccine Technologies Market Share by Type (2019-2030)
    Figure 25. Europe Vaccine Technologies Market Share by Application (2019-2030)
    Figure 26. Europe Vaccine Technologies Market Share by Country (2019-2030)
    Figure 27. Germany Vaccine Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Vaccine Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Vaccine Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Vaccine Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Vaccine Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Vaccine Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China Vaccine Technologies Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China Vaccine Technologies Market Share by Type (2019-2030)
    Figure 35. China Vaccine Technologies Market Share by Application (2019-2030)
    Figure 36. Asia Vaccine Technologies Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia Vaccine Technologies Market Share by Type (2019-2030)
    Figure 38. Asia Vaccine Technologies Market Share by Application (2019-2030)
    Figure 39. Asia Vaccine Technologies Market Share by Region (2019-2030)
    Figure 40. Japan Vaccine Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Vaccine Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Vaccine Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Vaccine Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Vaccine Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Vaccine Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Vaccine Technologies Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Vaccine Technologies Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Vaccine Technologies Market Share by Application (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Vaccine Technologies Market Share by Country (2019-2030)
    Figure 50. Brazil Vaccine Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico Vaccine Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey Vaccine Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Vaccine Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel Vaccine Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries Vaccine Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Abbott Revenue Growth Rate in Vaccine Technologies Business (2019-2024)
    Figure 57. Pfizer Revenue Growth Rate in Vaccine Technologies Business (2019-2024)
    Figure 58. Bayer Revenue Growth Rate in Vaccine Technologies Business (2019-2024)
    Figure 59. GE Healthcare Revenue Growth Rate in Vaccine Technologies Business (2019-2024)
    Figure 60. Glaxosmithkline Revenue Growth Rate in Vaccine Technologies Business (2019-2024)
    Figure 61. Johnson and Johnson Revenue Growth Rate in Vaccine Technologies Business (2019-2024)
    Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Vaccine Technologies Business (2019-2024)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS